---
audienceLevel: patient
cancerTypes:
- breast
- colorectal
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Tucatinib - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/tucatinib
version: v1
---

# Tucatinib - NCI

# Tucatinib

Placeholder slot

(too-KA-tih-nib)

Tucatinib works by binding to the part of the HER2 protein that is inside the cell, preventing it from sending signals that promote cell growth. It is a type of targeted therapy drug called a tyrosine kinase inhibitor. It is a small-molecule drug (a drug that can enter cells easily).

US Brand Name(s)

Tukysa

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f27eb1b9-b7fc-424e-988f-84dd7bb195a3&audience=consumer)

## Use in Cancer

Tucatinib
is approved to treat adults whose cancer is [HER2 positive](/Common/PopUps/popDefinition.aspx?id=737998&version=Patient&language=English), including:

- **[Breast cancer](/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=English)** that cannot be removed by surgery or has spread to other parts of the body, such as the [brain](/Common/PopUps/popDefinition.aspx?id=797669&version=Patient&language=English). It is used with [trastuzumab](/Common/PopUps/popDefinition.aspx?id=45439&version=Patient&language=English) and [capecitabine](/Common/PopUps/popDefinition.aspx?id=45565&version=Patient&language=English) in patients who have received at least one anti-HER2 treatment for cancer that has spread to other parts of the body.
- **[Colorectal cancer](/Common/PopUps/popDefinition.aspx?id=444983&version=Patient&language=English)** that cannot be removed by surgery or has spread to other parts of the body and has the [wild-type](/Common/PopUps/popDefinition.aspx?id=790142&version=Patient&language=English) *[RAS](/Common/PopUps/popDefinition.aspx?id=45859&version=Patient&language=English)* gene. It is used with trastuzumab in patients who have received treatment that included a [fluoropyrimidine](/Common/PopUps/popDefinition.aspx?id=386207&version=Patient&language=English),
[oxaliplatin](/Common/PopUps/popDefinition.aspx?id=45465&version=Patient&language=English), and [irinotecan hydrochloride](/Common/PopUps/popDefinition.aspx?id=635811&version=Patient&language=English) and it did not work or is no longer working.¹

¹This use is approved under FDA’s [Accelerated Approval Program](https://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm). As a condition of approval, a [confirmatory trial(s)](/Common/PopUps/popDefinition.aspx?id=799146&version=Patient&language=English) must show that tucatinib provides a clinical benefit in these patients.

Tucatinib
is also being studied in the treatment of other types of
cancer.

## More About Tucatinib

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/594366) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Tucatinib](https://medlineplus.gov/druginfo/meds/a620032.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal Cancer](https://www.cancer.gov/news-events/cancer-currents-blog/2023/fda-tucatinib-her2-colorectal-cancer)

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Tucatinib](https://www.cancer.gov/research/participate/clinical-trials/intervention/C77896) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
